Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Predicted Market Size Trajectory For The Disseminated Intravascular Coagulation (DIC) Market From 2025 To 2034?
The market size for disseminated intravascular coagulation (dic) has consistently expanded in recent years. It is projected to increase from $0.46 billion in 2024 to $0.49 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.0%. This historical growth can be attributed to several factors including a rise in the prevalence of sepsis, an increase in trauma cases, higher cancer incidence, increased healthcare spending, improved awareness among healthcare professionals, and a greater adoption of targeted therapies.
The disseminated intravascular coagulation (dic) market size is anticipated to experience consistent expansion in the coming years. It is projected to reach $0.59 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 4.9%. This projected growth can be ascribed to several factors, including the increasing uptake of targeted therapies, a heightened focus on early disease detection, escalating investments in healthcare infrastructure, the expansion of clinical research into coagulopathy treatments, and greater awareness of rare hematological conditions. Key trends expected within the forecast period comprise advancements in diagnostic assays, the integration of novel anticoagulant therapies, the adoption of personalized medicine approaches, the incorporation of AI in diagnostics, improved patient monitoring technologies, and the continued development of targeted treatments.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21172&type=smp
Which Drivers Are Shaping The Disseminated Intravascular Coagulation (DIC) Industry’s Market Share?
The anticipated growth of the disseminated intravascular coagulation (DIC) market is expected to be driven by the increasing prevalence of cancer. Cancer is an illness characterized by the uncontrolled proliferation and spread of abnormal cells throughout the body, which can invade and damage normal tissues. The rise in cancer cases stems from various factors, including an aging population, lifestyle modifications, environmental exposures, infections, and genetic susceptibility. Cancer can lead to disseminated intravascular coagulation (DIC) by triggering excessive activation of the coagulation cascade through tumor-produced procoagulant substances, resulting in widespread clotting and bleeding. For example, in May 2024, the National Cancer Institute, a US-based government agency, reported that approximately 20 million new cancer cases and 9.7 million cancer-related deaths were recorded worldwide in 2022. Projections indicate these numbers could escalate to 29.9 million new cases and 15.3 million deaths annually by 2040. Therefore, the expanding incidence of cancer is propelling the growth of the disseminated intravascular coagulation (DIC) market.
What Are The Major Segment Categories Driving The Disseminated Intravascular Coagulation (DIC) Market Growth?
The disseminated intravascular coagulation (dic)market covered in this report is segmented –
1) By Treatment: Medicines; Transfusions; Surgery; Other Treatments
2) By Diagnosis: Complete Blood Count With Blood Smear Exam; Partial Thromboplastin Time (PTT); Fibrinogen Blood Test; D-dimer; Other Diagnoses
3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
Subsegments:
1) By Medicines: Anticoagulants; Antiplatelet Drugs; Fibrinolytics; Procoagulants; Antithrombin Therapy
2) By Transfusions: Platelet Transfusion; Fresh Frozen Plasma (FFP); Cryoprecipitate Transfusion; Red Blood Cell Transfusion
3) By Surgery: Surgical Removal Of Thrombus; Organ Surgery
4) By Other Treatments: Plasma Exchange; Supportive Care; Steroid Therapy
How Are Emerging Market Trends Shaping The Disseminated Intravascular Coagulation (DIC) Industry Landscape?
Companies operating within the disseminated intravascular coagulation (DIC) market are concentrating on developing advanced coagulation diagnostic technologies, such as novel blood clotting tests, to improve the accuracy, speed, and ease of diagnosing DIC, which in turn enables timely interventions and better patient outcomes. These next-generation blood clotting tests refer to sophisticated diagnostic tools and methods designed to assess blood coagulation more precisely, efficiently, and comprehensively than traditional approaches. For example, in June 2022, LumiraDx Limited, a UK-based healthcare company, broadened its cardiovascular testing portfolio after receiving CE Mark approvals for its NT-proBNP and updated D-Dimer tests. These particular tests enhance the LumiraDx Platform’s capability to support clinicians in diagnosing heart failure and ruling out venous thromboembolism directly at the point of care. The overall goal of these advancements is to enhance the early detection and management of cardiovascular and thrombotic conditions, including disseminated intravascular coagulation (DIC).
Who Are The Core Companies Influencing The Disseminated Intravascular Coagulation (DIC) Market Landscape?
Major companies operating in the disseminated intravascular coagulation (DIC) market are Nihon Kohden Corporation, Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., AbbVie Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, Thermo Fisher Scientific Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Danaher Corporation, Eli Lily and Company, Siemens Healthineers, Teva Pharmaceutical Industries Ltd., Mylan N.V., Grifols S.A., Eisai Co. Ltd., Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc.
Download The Full Report For Exclusive Market Findings:
Which Regional Markets Are Contributing Most To The Disseminated Intravascular Coagulation (DIC) Industry Expansion?
North America was the largest region in the disseminated intravascular coagulation (DIC) market in 2024. The regions covered in the disseminated intravascular coagulation (DIC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Disseminated Intravascular Coagulation (DIC) Market Report:
https://www.thebusinessresearchcompany.com/customise?id=21172&type=smp
Browse Through More Reports Similar to the Global Disseminated Intravascular Coagulation (DIC) Market 2025, By The Business Research Company
Intravascular Catheters Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/intravascular-catheters-global-market-report
Coagulation Analyzer Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/coagulation-analyzer-global-market-report
Point Of Care Poc Coagulation Testing Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model